The injection still wins when the goal is the largest possible weight loss, when type 2 diabetes and cardiovascular risk are part of the picture, or when a patient is already doing well on tirzepatide
Red flags for reconsidering the diagnosis: Unilateral disease Atypical distribution Poor response to standard HS therapy Deep fluctuant masses or lymphadenopathy Missing this matters because treating presumed HS with immunosuppressants (e.g., biologics) could worsen underlying TB
Why activate glucagon if it raises blood sugar
What results are associated with NA-931
All Mochi plans include: 24/7 patient support Direct provider messaging An online portal for booking visits, managing prescriptions and tracking progress Their Health + Medication Plan includes regular video visits with a physician and registered dietitian, a weight loss prescription, and options for labs, genetic testing, and sleep apnea assessments